Leerink Partners


Overall Ranking (100%)

The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.

The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.

The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.

The Overall Ranking is generated based on the Company Reviews.

  • 5 Stars
  • 4 Stars
  • 3 Stars
  • 2 Stars
  • 1 Star

Company Details

Leerink Swann combines financial expertise and healthcare insight to enable clients to make the best informed investment decisions. Leerink is an investment bank focused on the health care industry. The investment bank provides brokerage, equity research, corporate finance, and strategic advisory services to companies and institutional investors in the health care and life sciences fields. Research areas include biotechnology, pharmaceuticals, medical devices, health care facilities, and health care technology. Leerink Swann also provides investment advisory services to life sciences companies, medical professionals, and high-net-worth investors.



One Federal Street, 37th Floor
37th Floor
Boston, MA 02110
United States

1251 Avenue of the Americas
22nd Floor
New York, NY 10020
United States

201 Spear Street
16th Floor
San Francisco, CA 94105
United States

Get Full Access

 or Register to Contribute

Recent interviews

View all
20181st Year Analystnew yorkInvestment BankingPositiveAverage
20191st Year AnalystBostonHealthcareNeutralAverage
2018InternNew YorkInvestment BankingPositiveAverage
2019Student / Prospective MonkeyNew YorkInvestment BankingPositiveDifficult

Leerink Partners

Investment Banking

Est Annual Revenue: